Brief: Arrowhead Pharmaceuticals - Issues $700 Million Of 0.00% Convertible Notes Due 2032 - SEC Filing
12/01/2026 23:10
Jan 12 (Reuters) - SEC Filing: ARROWHEAD PHARMACEUTICALS - ISSUES $700 MILLION OF 0.00% CONVERTIBLE NOTES DUE 2032 - SEC FILING Source text: [ID:n0001193125-26-010582] Further company coverage: ARWR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arrowhead Pharmaceuticals
See all newsBrief: Uk's MHRA Authorises Redemplo For Adults With Familial Chylomicronaemia Syndrome
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Brief: Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers